ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ABBV AbbVie Inc

159.6218
-7.67 (-4.58%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
AbbVie Inc ABBV NYSE 普通株式
  前日比 前日比 % 現在値 時刻
-7.67 -4.58% 159.6218 08:59:10
始値 安値 高値 終値 前日終値
167.26 157.65 167.46 159.62 167.29
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2620:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
2024/4/2620:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
2024/4/2521:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
2024/4/2321:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
2024/4/1821:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
2024/4/1220:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
2024/4/0921:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
2024/4/0421:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
2024/4/0321:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
2024/4/0120:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
2024/3/2620:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
2024/3/2600:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
2024/3/2521:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
2024/3/2521:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
2024/3/2304:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
2024/3/2121:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
2024/3/0722:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
2024/3/0622:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
2024/3/0607:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0602:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
2024/3/0522:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
2024/3/0521:00PRNCADragonfly has Received Milestone Payment Following Dosing of..
2024/3/0209:53EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:20EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0108:06EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0107:33EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0106:04EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2814:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
2024/2/2807:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2722:00PRNUSAbbVie to Present at the TD Cowen 44th Annual Health Care..
2024/2/2721:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
2024/2/2707:08EDGAR2Form 8-K - Current report
2024/2/2620:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:04EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2222:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
2024/2/2208:00EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2122:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2122:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
2024/2/2107:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock